HRGN (Harvard Apparatus Regenerative Technology) Cyclically Adjusted FCF per Share: $-2.60 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HRGN Harvard Apparatus Regenerative Technology Inc HRGN
14 GF Score
Price $1.05
! 2 Warning Signs
View Full Analysis

What is Harvard Apparatus Regenerative Technology Cyclically Adjusted FCF per Share?

Harvard Apparatus Regenerative Technology HRGN 14 Cyclically Adjusted FCF per Share is $-2.60 as of Mar. 2026. GuruFocus rates HRGN with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Harvard Apparatus Regenerative Technology's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.053. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-2.60 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 32.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Harvard Apparatus Regenerative Technology was 32.50% per year. The lowest was 32.50% per year. And the median was 32.50% per year.

As of today (2026-07-28), Harvard Apparatus Regenerative Technology's current stock price is $1.05. Harvard Apparatus Regenerative Technology's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-2.60. Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF of today is .


Harvard Apparatus Regenerative Technology  (OTCPK:HRGN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Harvard Apparatus Regenerative Technology Cyclically Adjusted FCF per Share Related Terms


Harvard Apparatus Regenerative Technology Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Harvard Apparatus Regenerative Technology's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harvard Apparatus Regenerative Technology Cyclically Adjusted FCF per Share Chart

Harvard Apparatus Regenerative Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -9.93 -7.61 -4.75 -3.05

Harvard Apparatus Regenerative Technology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.30 -3.80 -3.38 -3.05 -2.60

HRGN vs JVA, BRLS, LIMX: Cyclically Adjusted FCF per Share Comparison

For the Packaged Foods subindustry, Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harvard Apparatus Regenerative Technology Cyclically Adjusted Price-to-FCF vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Harvard Apparatus Regenerative Technology's Cyclically Adjusted Price-to-FCF falls into.


HRGN
14GF Score
Harvard Apparatus Regenerative Technology Inc HRGN
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harvard Apparatus Regenerative Technology Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Harvard Apparatus Regenerative Technology's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.053/330.2130*330.2130
=-0.053

Current CPI (Mar. 2026) = 330.2130.

Harvard Apparatus Regenerative Technology Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -2.050 241.018 -2.809
201609 -2.449 241.428 -3.350
201612 -3.572 241.432 -4.886
201703 -2.325 243.801 -3.149
201706 -1.702 244.955 -2.294
201709 -1.633 246.819 -2.185
201712 -0.816 246.524 -1.093
201803 -0.750 249.554 -0.992
201806 -0.337 251.989 -0.442
201809 -0.399 252.439 -0.522
201812 -0.385 251.233 -0.506
201903 -0.207 254.202 -0.269
201906 -0.317 256.143 -0.409
201909 -0.194 256.759 -0.249
201912 -0.187 256.974 -0.240
202003 -0.132 258.115 -0.169
202006 -0.124 257.797 -0.159
202009 -0.097 260.280 -0.123
202012 -0.109 260.474 -0.138
202103 -0.060 264.877 -0.075
202106 -0.063 271.696 -0.077
202109 -0.045 274.310 -0.054
202112 -0.088 278.802 -0.104
202203 -0.048 287.504 -0.055
202206 -0.101 296.311 -0.113
202209 -0.148 296.808 -0.165
202212 -0.147 296.797 -0.164
202303 -0.084 301.836 -0.092
202306 -0.112 305.109 -0.121
202309 -0.228 307.789 -0.245
202312 -0.087 306.746 -0.094
202403 -0.069 312.332 -0.073
202406 -0.091 314.175 -0.096
202409 -0.098 315.301 -0.103
202412 -0.071 315.605 -0.074
202503 -0.048 319.799 -0.050
202506 -0.059 322.561 -0.060
202509 -0.086 324.800 -0.087
202512 -0.039 324.054 -0.040
202603 -0.053 330.213 -0.053

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-2.60 mean?
Harvard Apparatus Regenerative Technology (HRGN) has a Cyclically Adjusted FCF per Share of $-2.60 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Harvard Apparatus Regenerative Technology and its competitors.
Is Harvard Apparatus Regenerative Technology's Cyclically Adjusted FCF per Share too high?
Harvard Apparatus Regenerative Technology's current Cyclically Adjusted FCF per Share is $-2.60. Overall, Harvard Apparatus Regenerative Technology has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's Cyclically Adjusted FCF per Share compare to JVA and BRLS?
Harvard Apparatus Regenerative Technology's Cyclically Adjusted FCF per Share of $-2.60 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted FCF per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Harvard Apparatus Regenerative Technology and its competitors. Harvard Apparatus Regenerative Technology's current Cyclically Adjusted FCF per Share is $-2.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Harvard Apparatus Regenerative Technology (HRGN) has a current Cyclically Adjusted FCF per Share of $-2.60. The current Cyclically Adjusted FCF per Share is $-2.60. Harvard Apparatus Regenerative Technology's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current Cyclically Adjusted FCF per Share is $-2.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Harvard Apparatus Regenerative Technology Business Description

Address 84 October Hill Road, Suite 11, Holliston, MA, USA, 01746
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
14GF Score

Get the complete analysis for HRGN

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.05
Price